BMI, BSA and Dosing Weight Calculator

BMI on the Asian cut-offs, body surface area, and the dosing weights a chart asks for · v1

  • Enter weight, height, sex and the reference standard to grade BMI against, Asian or WHO.
  • You get BMI with its category, DuBois body surface area, and the actual, ideal and adjusted body weights used in pharmacokinetics.
  • You also get the ARDSNet tidal volume at 8 and 6 mL/kg, computed from predicted body weight and never from actual weight.
  • What it hands back is the weight to calculate a dose from, not the dose. The table below says which weight each drug class takes.

  • Children and adolescents. It carries no growth chart and no centile.
  • A correction for amputation, or for pregnancy.
  • Waist circumference and abdominal obesity, which the Asian Indian definition also uses and which BMI alone does not capture in this phenotype.
  • The Mosteller body surface area, which reads about 3 per cent higher in obese men and 5 per cent higher in obese women. This tool computes DuBois only.
  • The dose of any drug. It gives the weight a dose is calculated from, and in adults the fluoroquinolones are given at a fixed dose and scaled to no weight at all.

Adult Patient Parameters

Evidence & Pearls

1. The "Thin-Fat" Indian Phenotype

Why the Asian cut-offs sit lower: At the same BMI, a South Asian patient carries less muscle and more visceral fat than a Caucasian one. That is the "thin-fat" phenotype. The central fat is what drives the insulin resistance, the metabolic syndrome and the coronary disease that arrives early, so the Association of Physicians of India (API) sets the thresholds lower: overweight from 23.0, obese from 25.0. A patient who is reassured by a BMI of 24 on the WHO scale is already overweight on this one.

2. Pharmacokinetics: Which Weight to Use?

A hydrophilic drug does not enter fat, so it distributes into much the same volume in an obese patient as in a lean one. Dose it on actual weight and the patient is overdosed. Which weight to use is a property of the drug, not of the patient.

Drug Property Weight to Use Clinical Examples
Hydrophilic
Does not distribute well into fat
Ideal Body Weight (IBW) Beta-lactams, Digoxin, Theophylline.
Partially Lipophilic
Moderate fat distribution
Adjusted Body Weight (AdjBW)
IBW + 0.4(Actual - IBW)
Aminoglycosides (Amikacin, Gentamicin).
Dosed on Actual Weight
Volume of distribution tracks total body weight
Actual Body Weight (ABW) Vancomycin, LMWH (Enoxaparin).

Fluoroquinolones are not on this table. In adults they are given at a fixed dose and are not scaled to body weight at all.

3. ARDSNet Lung-Protective Ventilation

Practice Advisory: Tidal volume is set from Predicted Body Weight (PBW), never from actual weight. Lung size follows height and biological sex. Fat adds none of it. Set 8 mL/kg against the actual weight of an obese patient and the breath delivered is far larger than the lung it is going into. That is volutrauma and barotrauma, and it is the injury lung-protective ventilation exists to prevent.
Abbreviations: ABW (Actual Body Weight) · AdjBW (Adjusted Body Weight) · API (Association of Physicians of India) · ARDS (Acute Respiratory Distress Syndrome) · ARDSNet (Acute Respiratory Distress Syndrome Network) · BMI (Body Mass Index) · BSA (Body Surface Area) · IBW (Ideal Body Weight) · LMWH (Low Molecular Weight Heparin) · PBW (Predicted Body Weight) · Vd (Volume of Distribution) · WHO (World Health Organization)
References
  1. Misra A, et al. Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian Indians and Recommendations for Physical Activity, Medical and Surgical Management. J Assoc Physicians India. 2009;57:163-170.
  2. The Acute Respiratory Distress Syndrome Network. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. N Engl J Med. 2000;342(18):1301-1308.
  3. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17(6):863-871.
  4. Pai MP, Paloucek FP. The origin of the "ideal" body weight equations. Ann Pharmacother. 2000;34(9):1066-1069.
  5. Misra A, Vikram NK, Ghosh A, Ranjan P, Gulati S; India Obesity Commission. Revised definition of obesity in Asian Indians living in India. Diabetes Metab Syndr. 2025;19(1):102989.
  6. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163.
  7. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. Geneva: WHO; 2000.
  8. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.
  9. Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism. 2006;55(4):515-524.
  10. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;58(2):119-133.
How to Cite This Tool

DOIhttps://doi.org/10.5281/zenodo.22401560

AMA Style:Umakanth S. BMI, BSA and Dosing Weight Calculator. Version 1. MEDiscuss Clinical Decision Support System. Published 2026. Accessed . https://mediscuss.org/cdss/bmi-bsa. doi:10.5281/zenodo.22401560

Vancouver Style:Umakanth S. BMI, BSA and Dosing Weight Calculator [Internet]. Version 1. MEDiscuss.org; 2026 [cited ]. Available from: https://mediscuss.org/cdss/bmi-bsa. doi:10.5281/zenodo.22401560

Category Foundational CalculatorsCalculator
Specialties Internal Medicine

Written and maintained by

Dr Shashikiran Umakanth

Last revised 24 August 2026

How these tools are written and reviewed